{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:23:18Z","timestamp":1790043798207,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH US","award":["1R01HL142893-01"],"award-info":[{"award-number":["1R01HL142893-01"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["23POST909139"],"award-info":[{"award-number":["23POST909139"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Dilated cardiomyopathy (DCM) and cardiac sarcoidosis (CS) manifest unique late gadolinium enhancement (LGE) patterns on cardiac magnetic resonance (CMR), indicative of different myocardial scar distributions. However, the overlap in these patterns due to their lack of specificity complicates differentiation. This study introduces a novel quantitative method employing <jats:italic>z<\/jats:italic>-score analysis of LGE-CMR intensity to objectively compare the spatial distribution of LGE intensity between DCM and CS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective study included 22 NICM patients (13 DCM, 9 CS) who underwent CMR before electrophysiology study from November 2018 to May 2023. LGE images were delineated into sub-endocardial, mid-myocardial, and sub-epicardial layers across anterior, lateral, inferior, and septal walls using the AHA 17-segment model. CMR signal intensities were standardized to <jats:italic>z<\/jats:italic>-scores (<jats:italic>z<\/jats:italic>\u2009= (<jats:italic>x<\/jats:italic>\u2009\u2212\u2009<jats:italic>\u03bc<\/jats:italic>)\/<jats:italic>\u03c3<\/jats:italic>), with <jats:italic>x<\/jats:italic> as the signal intensity for a specific myocardial segment, and <jats:italic>\u03bc<\/jats:italic> and <jats:italic>\u03c3<\/jats:italic> as the mean and SD for all LV myocardial segments, to map regional intensity variations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to DCM, CS patients exhibited significantly higher CMR signal intensity <jats:italic>z<\/jats:italic>-scores in the septum (<jats:italic>\u03b2<\/jats:italic>\u2009= 0.32, <jats:italic>p<\/jats:italic>\u2009= 0.009), particularly in the endocardial third of the right ventricular (RV) side (<jats:italic>\u03b2<\/jats:italic>\u2009= 0.56, <jats:italic>p<\/jats:italic>\u2009= 0.001). A <jats:italic>z<\/jats:italic>-score greater than 0.40 in this area was associated with a CS diagnosis, with an area under the ROC curve of 0.692 in fivefold cross-validation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Patients with CS exhibit higher affinity for contrast in the septum, particularly on the RV endocardium. Standardized analysis of CMR signal intensities provides a novel, quantitative method for distinguishing CS from DCM, with the former exhibiting higher CMR signal intensity <jats:italic>z<\/jats:italic>-scores in the septum.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s10840-025-02042-7","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T23:14:00Z","timestamp":1746486840000},"page":"1593-1604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative cardiac magnetic resonance standardized signal intensity comparison in dilated cardiomyopathy vs. cardiac sarcoidosis"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2345-0154","authenticated-orcid":false,"given":"Ting-Wei Ernie","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-8371","authenticated-orcid":false,"given":"Lingyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1479-5038","authenticated-orcid":false,"given":"Mirmilad Pourmousavi","family":"Khoshknab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-4376","authenticated-orcid":false,"given":"Paco E.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0693-4982","authenticated-orcid":false,"given":"Benoit","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8369-0259","authenticated-orcid":false,"given":"Saman","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"44","key":"2042_CR1","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"2023","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T, Elliott PM, Flather M, Garcia-Pavia P, Haugaa KH, Ingles J, Jurcut RO, Klaassen S, Limongelli G, Loeys B, Mogensen J, Olivotto I, Pantazis A, Sharma S, Van Tintelen JP, Ware JS, Kaski JP, E.S.C.S.D. Group. ESC guidelines for the management of cardiomyopathies. Eur Heart J. 2023;2023(44):3503\u2013626.","journal-title":"Eur Heart J."},{"issue":"4","key":"2042_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.hroo.2023.01.001","volume":"O2","author":"M Al-Sadawi","year":"2023","unstructured":"Al-Sadawi M, Aslam F, Tao M, Fan R, Singh A, Rashba E. Association of late gadolinium enhancement in cardiac magnetic resonance with mortality, ventricular arrhythmias, and heart failure in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis. Heart Rhythm. 2023;O2(4):241\u201350.","journal-title":"Heart Rhythm"},{"key":"2042_CR3","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","volume":"135","author":"BP Halliday","year":"2017","unstructured":"Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, Vassiliou VS, Lota A, Izgi C, Tayal U, Khalique Z, Stirrat C, Auger D, Pareek N, Ismail TF, Rosen SD, Vazir A, Alpendurada F, Gregson J, Frenneaux MP, Cowie MR, Cleland JGF, Cook SA, Pennell DJ, Prasad SK. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation. 2017;135:2106\u201315.","journal-title":"Circulation"},{"key":"2042_CR4","doi-asserted-by":"publisher","first-page":"e010105","DOI":"10.1161\/CIRCIMAGING.119.010105","volume":"13","author":"AC Alba","year":"2020","unstructured":"Alba AC, Gaztanaga J, Foroutan F, Thavendiranathan P, Merlo M, Alonso-Rodriguez D, Vallejo-Garcia V, Vidal-Perez R, Corros-Vicente C, Barreiro-Perez M, Pazos-Lopez P, Perez-David E, Dykstra S, Flewitt J, Perez-Rivera JA, Vazquez-Caamano M, Katz SD, Sinagra G, Kober L, Poole J, Ross H, Farkouh ME, White JA. Prognostic value of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy: an international, multi-institutional study of the MINICOR group. Circ Cardiovasc Imaging. 2020;13:e010105.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2042_CR5","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.jcmg.2018.07.015","volume":"12","author":"BP Halliday","year":"2019","unstructured":"Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, Arzanauskaite M, Lota A, Tayal U, Vassiliou VS, Gregson J, Alpendurada F, Frenneaux MP, Cook SA, Cleland JGF, Pennell DJ, Prasad SK. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC Cardiovasc Imaging. 2019;12:1645\u201355.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2042_CR6","doi-asserted-by":"publisher","unstructured":"Athwal PSS, Chhikara S, Ismail MF, Ismail K, Ogugua FM, Kazmirczak F, Bawaskar PH, Elton AC, Markowitz J, von Wald L, Roukoz H, Bhargava M, Perlman D, Shenoy C. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis. JAMA Cardiol. 2022;7(10):1057\u20131066. https:\/\/doi.org\/10.1001\/jamacardio.2022.2981.","DOI":"10.1001\/jamacardio.2022.2981"},{"key":"2042_CR7","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","volume":"44","author":"J Lehtonen","year":"2023","unstructured":"Lehtonen J, Uusitalo V, Poyhonen P, Mayranpaa MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J. 2023;44:1495\u2013510.","journal-title":"Eur Heart J"},{"key":"2042_CR8","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, Inomata T, Ishibashi-Ueda H, Eishi Y, Kitakaze M, Kusano K, Sakata Y, Shijubo N, Tsuchida A, Tsutsui H, Nakajima T, Nakatani S, Horii T, Yazaki Y, Yamaguchi E, Yamaguchi T, Ide T, Okamura H, Kato Y, Goya M, Sakakibara M, Soejima K, Nagai T, Nakamura H, Noda T, Hasegawa T, Morita H, Ohe T, Kihara Y, Saito Y, Sugiyama Y, Morimoto SI, Yamashina A, G. Japanese Circulation Society Joint Working. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version. Circ J. 2019;83:2329\u201388.","journal-title":"Circ J."},{"key":"2042_CR9","doi-asserted-by":"publisher","unstructured":"Sano M, Satoh H, Suwa K, Saotome M, Urushida T, Katoh H, Hayashi H, Saitoh T. Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy. World J Cardiol. 2016;8(9):496\u2013503. https:\/\/doi.org\/10.4330\/wjc.v8.i9.496.","DOI":"10.4330\/wjc.v8.i9.496"},{"key":"2042_CR10","doi-asserted-by":"publisher","first-page":"13775","DOI":"10.1038\/s41598-023-41087-4","volume":"13","author":"N Theerasuwipakorn","year":"2023","unstructured":"Theerasuwipakorn N, Chokesuwattanaskul R, Phannajit J, Marsukjai A, Thapanasuta M, Klem I, Chattranukulchai P. Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis. Sci Rep. 2023;13:13775.","journal-title":"Sci Rep"},{"key":"2042_CR11","doi-asserted-by":"publisher","unstructured":"Reinhold JC, Dewey BE, Carass A, Prince JL. Evaluating the Impact of Intensity Normalization on MR Image Synthesis. Proc SPIE Int Soc Opt Eng. 2019;10949:109493H. https:\/\/doi.org\/10.1117\/12.2513089.","DOI":"10.1117\/12.2513089"},{"key":"2042_CR12","first-page":"88","volume":"20","author":"KA Wahid","year":"2021","unstructured":"Wahid KA, He R, McDonald BA, Anderson BM, Salzillo T, Mulder S, Wang J, Sharafi CS, McCoy LA, Naser MA, Ahmed S, Sanders KL, Mohamed ASR, Ding Y, Wang J, Hutcheson K, Lai SY, Fuller CD, van Dijk LV. Intensity standardization methods in magnetic resonance imaging of head and neck cancer, Phys Imaging. Radiat Oncol. 2021;20:88\u201393.","journal-title":"Radiat Oncol"},{"key":"2042_CR13","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1161\/01.CIR.96.6.1863","volume":"96","author":"RS Vasan","year":"1997","unstructured":"Vasan RS, Larson MG, Levy D, Evans JC, Benjamin EJ. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation. 1997;96:1863\u201373.","journal-title":"Circulation"},{"issue":"93","key":"2042_CR14","first-page":"841","volume":"1995","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O\u2019Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;1995(93):841\u20132.","journal-title":"Circulation."},{"key":"2042_CR15","doi-asserted-by":"publisher","unstructured":"Xu L, Khoshknab M, Moss J, Yang LC, Berger RD, Chrispin J, Callans D, Marchlinski FE, Zimmerman SL, Han Y, Trayanova N, Witschey WR, Desjardins B, Nazarian S. Lipomatous Metaplasia Facilitates Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy. JACC Clin Electrophysiol. 2024;10(11):2325\u20132336. https:\/\/doi.org\/10.1016\/j.jacep.2024.07.017.","DOI":"10.1016\/j.jacep.2024.07.017"},{"key":"2042_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCIMAGING.111.965764","volume":"4","author":"T Sasaki","year":"2011","unstructured":"Sasaki T, Hansford R, Zviman MM, Kolandaivelu A, Bluemke DA, Berger RD, Calkins H, Halperin HR, Nazarian S. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc Imaging. 2011;4:662\u201370.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2042_CR17","doi-asserted-by":"publisher","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, S, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation.2002;105:539\u2013542. https:\/\/doi.org\/10.1161\/hc0402.102975","DOI":"10.1161\/hc0402.10297"},{"key":"2042_CR18","doi-asserted-by":"crossref","unstructured":"Haas GJ, Zareba KM, Ni H, Bello-Pardo E, Huggins GS, Hershberger RE. I study principal U Co-investigators: the Ohio state, validating an idiopathic dilated cardiomyopathy diagnosis using cardiovascular magnetic resonance: the dilated cardiomyopathy precision medicine study. Circ Heart Fail. 2022;15:e008877.","DOI":"10.1161\/CIRCHEARTFAILURE.121.008877"},{"key":"2042_CR19","doi-asserted-by":"publisher","first-page":"e011253","DOI":"10.1161\/JAHA.118.011253","volume":"8","author":"O Okasha","year":"2019","unstructured":"Okasha O, Kazmirczak F, Chen KA, Farzaneh-Far A, Shenoy C. Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: a systematic review and meta-analysis of gross pathological images from autopsy or cardiac transplantation cases. J Am Heart Assoc. 2019;8:e011253.","journal-title":"J Am Heart Assoc"},{"key":"2042_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cardfail.2014.12.004","volume":"21","author":"D Tezuka","year":"2015","unstructured":"Tezuka D, Terashima M, Kato Y, Toriihara A, Hirasawa K, Sasaoka T, Yoshikawa S, Maejima Y, Ashikaga T, Suzuki J, Hirao K, Isobe M. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography\/computerized tomography. J Card Fail. 2015;21:313\u201322.","journal-title":"J Card Fail"},{"key":"2042_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","volume":"6","author":"S Greulich","year":"2013","unstructured":"Greulich S, Deluigi CC, Gloekler S, Wahl A, Zurn C, Kramer U, Nothnagel D, Bultel H, Schumm J, Grun S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6:501\u201311.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2042_CR22","doi-asserted-by":"publisher","unstructured":"Meier C, Eisenbl\u00e4tter M, Gielen S. Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease. J Cardiovasc Dev Dis. 2024;11(2):40. https:\/\/doi.org\/10.3390\/jcdd11020040.","DOI":"10.3390\/jcdd11020040"},{"key":"2042_CR23","doi-asserted-by":"crossref","unstructured":"Tat E, Ball C, Camren GP, Wroblewski I, Dajani KA, Goldberg A, Kinno M, Sanagala T, Syed MA, Wilber DJ, Rabbat M. Impact of late gadolinium enhancement extent, location, and pattern on ventricular tachycardia and major adverse cardiac events in patients with ischemic vs. non-ischemic cardiomyopathy. Front Cardiovasc Med. 2022;9:1026215.","DOI":"10.3389\/fcvm.2022.1026215"},{"key":"2042_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/jmri.26789","volume":"51","author":"A Seraphim","year":"2020","unstructured":"Seraphim A, Knott KD, Augusto J, Bhuva AN, Manisty C, Moon JC. Quantitative cardiac MRI. J Magn Reson Imaging. 2020;51:693\u2013711.","journal-title":"J Magn Reson Imaging"},{"key":"2042_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2463\/mrms.mp.2017-0136","volume":"18","author":"F Yanagisawa","year":"2019","unstructured":"Yanagisawa F, Amano Y, Tachi M, Inui K, Asai K, Kumita S. Non-contrast-enhanced T(1) mapping of dilated cardiomyopathy: comparison between native T(1) values and late gadolinium enhancement. Magn Reson Med Sci. 2019;18:12\u20138.","journal-title":"Magn Reson Med Sci"},{"key":"2042_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jcmg.2017.04.006","volume":"11","author":"S Nakamori","year":"2018","unstructured":"Nakamori S, Dohi K, Ishida M, Goto Y, Imanaka-Yoshida K, Omori T, Goto I, Kumagai N, Fujimoto N, Ichikawa Y, Kitagawa K, Yamada N, Sakuma H, Ito M. Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging. 2018;11:48\u201359.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2042_CR27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jacep.2020.10.002","volume":"7","author":"D Muser","year":"2021","unstructured":"Muser D, Nucifora G, Castro SA, Enriquez A, Chahal CAA, Magnani S, Kumareswaran R, Arkles J, Supple G, Schaller R, Hyman M, Dixit S, Lin D, Zado ES, Tschabrunn C, Callans DJ, Nazarian S, Frankel DS, Marchlinski FE, Santangeli P. Myocardial substrate characterization by CMR T(1) mapping in patients with NICM and no LGE undergoing catheter ablation of VT. JACC Clin Electrophysiol. 2021;7:831\u201340.","journal-title":"JACC Clin Electrophysiol"},{"key":"2042_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","volume":"189","author":"ED Crouser","year":"2014","unstructured":"Crouser ED, Ono C, Tran T, He X, Raman SV. Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med. 2014;189:109\u201312.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02042-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-025-02042-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02042-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:58:18Z","timestamp":1758956298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-025-02042-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1007\/s10840-025-02042-7","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All patients enrolled are registered under the Hospital of the University of Pennsylvania Cardiac Electrophysiology Registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Dr. Nazarian is a consultant to Dyne Pharmaceuticals and ADAS software and the principal investigator for research funding from Biosense Webster and the US NIH. The University of Pennsylvania Conflict of Interest Committee manages all commercial arrangements. The remaining authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}